Logo image of ATRI

ATRION CORPORATION (ATRI) Stock Fundamental Analysis

NASDAQ:ATRI - Nasdaq - US0499041053 - Common Stock - Currency: USD

459.92  +0.26 (+0.06%)

Fundamental Rating

5

ATRI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. While ATRI has a great health rating, its profitability is only average at the moment. ATRI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

ATRI had positive earnings in the past year.
In the past year ATRI had a positive cash flow from operations.
Each year in the past 5 years ATRI has been profitable.
Each year in the past 5 years ATRI had a positive operating cash flow.
ATRI Yearly Net Income VS EBIT VS OCF VS FCFATRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M 40M

1.2 Ratios

With an excellent Return On Assets value of 4.82%, ATRI belongs to the best of the industry, outperforming 82.72% of the companies in the same industry.
ATRI has a better Return On Equity (5.26%) than 77.49% of its industry peers.
ATRI has a better Return On Invested Capital (5.13%) than 78.53% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ATRI is above the industry average of 7.89%.
The last Return On Invested Capital (5.13%) for ATRI is well below the 3 year average (11.35%), which needs to be investigated, but indicates that ATRI had better years and this may not be a problem.
Industry RankSector Rank
ROA 4.82%
ROE 5.26%
ROIC 5.13%
ROA(3y)11.02%
ROA(5y)11.82%
ROE(3y)12.05%
ROE(5y)13%
ROIC(3y)11.35%
ROIC(5y)12.04%
ATRI Yearly ROA, ROE, ROICATRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20

1.3 Margins

ATRI has a Profit Margin of 6.92%. This is in the better half of the industry: ATRI outperforms 78.53% of its industry peers.
In the last couple of years the Profit Margin of ATRI has declined.
ATRI has a Operating Margin of 7.93%. This is in the better half of the industry: ATRI outperforms 75.39% of its industry peers.
ATRI's Operating Margin has declined in the last couple of years.
ATRI has a worse Gross Margin (32.08%) than 72.25% of its industry peers.
ATRI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 7.93%
PM (TTM) 6.92%
GM 32.08%
OM growth 3Y-18%
OM growth 5Y-13.39%
PM growth 3Y-19.22%
PM growth 5Y-12.62%
GM growth 3Y-6.34%
GM growth 5Y-4.8%
ATRI Yearly Profit, Operating, Gross MarginsATRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40

More info and screens

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ATRI is still creating some value.
ATRI has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ATRI has less shares outstanding
ATRI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ATRI Yearly Shares OutstandingATRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M
ATRI Yearly Total Debt VS Total AssetsATRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 25.99 indicates that ATRI is not in any danger for bankruptcy at the moment.
The Altman-Z score of ATRI (25.99) is better than 95.29% of its industry peers.
ATRI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 25.99
ROIC/WACC0.59
WACC8.7%
ATRI Yearly LT Debt VS Equity VS FCFATRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 6.80 indicates that ATRI has no problem at all paying its short term obligations.
With an excellent Current ratio value of 6.80, ATRI belongs to the best of the industry, outperforming 81.68% of the companies in the same industry.
ATRI has a Quick Ratio of 2.94. This indicates that ATRI is financially healthy and has no problem in meeting its short term obligations.
ATRI has a Quick ratio of 2.94. This is in the better half of the industry: ATRI outperforms 61.78% of its industry peers.
Industry RankSector Rank
Current Ratio 6.8
Quick Ratio 2.94
ATRI Yearly Current Assets VS Current LiabilitesATRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

ATRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -53.54%.
ATRI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.39% yearly.
Looking at the last year, ATRI shows a small growth in Revenue. The Revenue has grown by 6.00% in the last year.
The Revenue has been growing slightly by 2.13% on average over the past years.
EPS 1Y (TTM)-53.54%
EPS 3Y-14.81%
EPS 5Y-9.39%
EPS Q2Q%-93.89%
Revenue 1Y (TTM)6%
Revenue growth 3Y4.68%
Revenue growth 5Y2.13%
Sales Q2Q%11.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ATRI Yearly Revenue VS EstimatesATRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

ATRI is valuated quite expensively with a Price/Earnings ratio of 64.50.
ATRI's Price/Earnings ratio is a bit cheaper when compared to the industry. ATRI is cheaper than 68.06% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.59. ATRI is valued rather expensively when compared to this.
Industry RankSector Rank
PE 64.5
Fwd PE N/A
ATRI Price Earnings VS Forward Price EarningsATRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ATRI is valued a bit cheaper than 73.82% of the companies in the same industry.
ATRI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ATRI is cheaper than 84.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 29.25
EV/EBITDA 26.01
ATRI Per share dataATRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The decent profitability rating of ATRI may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.91%, ATRI has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.89, ATRI pays a better dividend. On top of this ATRI pays more dividend than 96.34% of the companies listed in the same industry.
ATRI's Dividend Yield is comparable with the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 1.91%

5.2 History

On average, the dividend of ATRI grows each year by 10.99%, which is quite nice.
ATRI has been paying a dividend for at least 10 years, so it has a reliable track record.
ATRI has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)10.99%
Div Incr Years20
Div Non Decr Years20
ATRI Yearly Dividends per shareATRI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

5.3 Sustainability

ATRI pays out 123.31% of its income as dividend. This is not a sustainable payout ratio.
ATRI's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP123.31%
EPS Next 2YN/A
EPS Next 3YN/A
ATRI Yearly Income VS Free CF VS DividendATRI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M
ATRI Dividend Payout.ATRI Dividend Payout, showing the Payout Ratio.ATRI Dividend Payout.PayoutRetained Earnings

More info and screens

ATRION CORPORATION

NASDAQ:ATRI (8/20/2024, 8:22:19 PM)

459.92

+0.26 (+0.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-05 2024-08-05/amc
Earnings (Next)11-05 2024-11-05/amc
Inst Owners1.01%
Inst Owner Change-45.73%
Ins Owners1.03%
Ins Owner Change0%
Market Cap809.46M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.91%
Yearly Dividend8.6
Dividend Growth(5Y)10.99%
DP123.31%
Div Incr Years20
Div Non Decr Years20
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 64.5
Fwd PE N/A
P/S 4.46
P/FCF 29.25
P/OCF 20.89
P/B 3.39
P/tB 3.55
EV/EBITDA 26.01
EPS(TTM)7.13
EY1.55%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)15.73
FCFY3.42%
OCF(TTM)22.02
OCFY4.79%
SpS103.18
BVpS135.72
TBVpS129.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.82%
ROE 5.26%
ROCE 5.93%
ROIC 5.13%
ROICexc 5.53%
ROICexgc 5.81%
OM 7.93%
PM (TTM) 6.92%
GM 32.08%
FCFM 15.24%
ROA(3y)11.02%
ROA(5y)11.82%
ROE(3y)12.05%
ROE(5y)13%
ROIC(3y)11.35%
ROIC(5y)12.04%
ROICexc(3y)13.26%
ROICexc(5y)14.73%
ROICexgc(3y)13.99%
ROICexgc(5y)15.58%
ROCE(3y)13.12%
ROCE(5y)13.92%
ROICexcg growth 3Y-18.15%
ROICexcg growth 5Y-19.86%
ROICexc growth 3Y-17.93%
ROICexc growth 5Y-19.35%
OM growth 3Y-18%
OM growth 5Y-13.39%
PM growth 3Y-19.22%
PM growth 5Y-12.62%
GM growth 3Y-6.34%
GM growth 5Y-4.8%
F-Score6
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 70.13%
Cap/Sales 6.1%
Interest Coverage 250
Cash Conversion 128.3%
Profit Quality 220.39%
Current Ratio 6.8
Quick Ratio 2.94
Altman-Z 25.99
F-Score6
WACC8.7%
ROIC/WACC0.59
Cap/Depr(3y)171.65%
Cap/Depr(5y)178.27%
Cap/Sales(3y)13.72%
Cap/Sales(5y)13.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.54%
EPS 3Y-14.81%
EPS 5Y-9.39%
EPS Q2Q%-93.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6%
Revenue growth 3Y4.68%
Revenue growth 5Y2.13%
Sales Q2Q%11.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-52.38%
EBIT growth 3Y-14.16%
EBIT growth 5Y-11.55%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.73%
OCF growth 3Y-20.1%
OCF growth 5Y-14.29%